SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending after delivering an exceptionally strong earnings report and bullish future guidance, primarily driven by surging demand for its high-bandwidth memory essential for AI infrastructure. The community is buzzing with optimism, widely discussing whether this robust performance signals that the broader AI narrative is fully intact and poised to uplift the tech sector, challenging recent market skepticism around other semiconductor stocks.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF (MSOS) is actively trending as the market anticipates an imminent executive order from President Trump to reclassify marijuana to Schedule III, potentially including vital banking reforms. This highly awaited move is driving significant community discussion and optimism, with investors foreseeing substantial benefits for US cannabis operators through reduced tax burdens and increased institutional investment. Many are holding strong, expecting a historic re-rating of the long-suppressed sector.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is trending as a federal designation confirmed its pipeline as an interstate facility, shifting regulatory authority and igniting debate on its path to renewed oil production. While many anticipate a significant operational restart and potential short squeeze, others remain cautious, highlighting continued state-level permit challenges and ongoing financial considerations. This development focuses community discussion on the interplay between offshore energy initiatives and regulatory frameworks.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals (PCSA) is trending due to positive Phase 2 study data for its breast cancer treatment, NGC-Cap, which showed increased drug efficacy without heightened side effects. This news, following a recent reverse stock split, has fueled significant volatility and discussions around its potential impact on the company's valuation. The community is actively debating whether the sharp price movements reflect a genuine re-rating or a volatile "pump and dump" scenario, with many traders discussing short attacks and the risk of further dilution.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is currently facing intense scrutiny and negative public sentiment in South Korea following a major data breach impacting millions of users and controversial responses from its leadership, including accusations of inadequate handling of worker safety incidents. This has led to heightened regulatory pressure, calls for boycotts, and widespread community discussion around CEO accountability, with some investors viewing the stock as oversold amid concerns of significant financial penalties and customer churn, while others anticipate a rebound due to the company's market dominance.

TOSHI

TOSHI is seeing a surge in conversation as the "Face of Base" meme coin, recently boosted by a Coinone KRW listing and ongoing speculation regarding future utility and major exchange listings. The community remains divided, with many actively "buying the dip" and expressing long-term conviction, while others voice frustration over market conditions and short-term price action.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending as the community eagerly awaits NASA's multi-billion dollar Lunar Terrain Vehicle (LTV) Services contract award, which many believe the company is uniquely positioned to win. Investors highlight LUNR's proven flight heritage and independent lander development as key advantages, sparking discussions on its potential valuation against market fluctuations and the impending announcement.

Ancient8 is the gaming L2 on Ethereum backed by Dragonfly, Pantera, Hashed, Coinbase Ventures and Makers Fund. Ancient8 offers a suite of Web3 gaming infrastructure tools that serve as the distribution and marketing channel for games globally.

Ancient8

Ancient8 ($A8) is trending as a recently listed gaming token, generating significant community buzz regarding its potential for a major price run, with some anticipating a breakout similar to other new exchange listings. However, the discussion is polarized, as a vocal segment warns of a potential 'rug pull' due to concentrated token ownership and alleged questionable developer practices.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is a top trending stock fueled by intense community anticipation of an imminent Executive Order to reschedule marijuana to Schedule III. This potential shift is generating significant discussion about alleviating tax burdens and opening doors for institutional investment in the cannabis sector, with investors actively debating its immediate market impact.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the Commercial Engines & Services and Defense & Propulsion Technologies segments. The Commercial Engines & Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense & Propulsion Technologies segment offers defense engines and critical aircraft systems. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is capturing investor interest with strong operational execution and a raised financial outlook, signaling robust demand across its commercial and defense aviation segments. The community is buzzing about strategic partnerships, including a significant investment in hybrid electric aviation and new engine deals, positioning the company for continued growth and sustained market strength. This momentum, amplified by recent analyst upgrades, underscores the perceived long-term value unlocked by its focused aerospace strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Biotech Stocks to Watch for Potential Upside

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position ARQT, FOLD, ANIP, TNGX and PCRX in this volatile sector. 

GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment

GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know

Rezolute shares collapse 79% so far in December after a phase III hyperinsulinism study of its only pipeline candidate miss primary and key secondary endpoints.

FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug

Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.

AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer

AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.

SNY Stock Down on Double Trouble With Multiple Sclerosis Drug

Sanofi shares slide after the FDA again delays its review of its MS drug tolebrutinib, and a phase III study fails to hit its primary endpoint.

KYTX Stock Rallies 23% on Upbeat Stiff Person Syndrome Study Data

Kyverna Therapeutics shares jump 23% after a registrational phase II study of miv-cel meets primary and all secondary efficacy goals for treating stiff person syndrome.

CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike

CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer

JNJ secures FDA approval to expand Akeega into earlier-stage prostate cancer, backed by strong phase III data and a first-of-its-kind precision combo.

GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.98	--	--	N/A
Q3 '25	$1.77	$2.04	15.25%	BEAT
Q2 '25	$1.41	$1.80	28.05%	BEAT
Q1 '25	$1.38	$1.70	22.97%	BEAT
Q4 '24	$1.43	$1.63	13.59%	BEAT

ANIP
ANI Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ANIP News

ANIPANI Pharmaceuticals Inc